|Other Names||Galactose-3-O-sulfotransferase 3, Gal3ST-3, 282-, Beta-galactose-3-O-sulfotransferase 3, Gal3ST3, Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3, GAL3ST3|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13192c was selected from the Center region of GAL3ST3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Transfers a sulfate to position 3 of non-reducing beta- galactosyl residues in N-glycans and core2-branched O-glycans. Has high activity towards Gal-beta-1,4-GlcNAc, Gal-beta-1,4(Fuc-alpha- 1,3)GlcNAc and lower activity towards Gal-beta-1,3(Fuc-alpha- 1,4)GlcNAc.|
|Cellular Location||Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein|
|Tissue Location||Highly expressed in thyroid, brain, kidney, heart and spinal cord.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of thegalactose-3-O-sulfotransferase protein family. The product of thisgene catalyzes sulfonation by transferring a sulfate group to the3' position of galactose in N-acetyllactosamine in both type 2(Gal-beta-1-4GlcNAc-R) oligosaccharides and core-2-branchedO-glycans, but not on type 1 or core-1-branched structures. Thisgene, which has also been referred to as GAL3ST2, is different fromthe GAL3ST2 gene located on chromosome 2 that encodes a relatedenzyme with distinct tissue distribution and substratespecificities, compared to galactose-3-O-sulfotransferase 3.
Chandrasekaran, E.V., et al. J. Biol. Chem. 279(11):10032-10041(2004)El-Fasakhany, F.M., et al. J. Biol. Chem. 276(29):26988-26994(2001)Seko, A., et al. J. Biol. Chem. 276(28):25697-25704(2001)Suzuki, A., et al. J. Biol. Chem. 276(26):24388-24395(2001)Chandrasekaran, E.V., et al. Glycoconj. J. 16(9):523-536(1999)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.